Treatment of women with constipation and urinary incontinence
- Conditions
- Constipation.
- Registration Number
- IRCT20230228057560N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 87
Women aged 18 to 60
Concomitant presence of constipation and stress urinary incontinence
At least 12 months have passed since symptoms
Have not responded to standard medical treatments for constipation and adherence to diet
not receiveing treatment regarding these two disorders.
Having at least two Criterion of the Rome IV criteria
Unsuccessful history of biofeedback therapy
Uncontrolled cardiovascular, kidney and liver diseases
Back, hip and/or hip joint dysfunction
Diabetes
Chronic obstructive pulmonary disease
Sexual problems
Use of medications (diuretics, sympathomimetics/sympatholytic), parasympathomimetic / parasympatholytic)
Spinal cord injury
Patients with a history of mental illness
Drug-induced constipation
Metabolic, endocrine, neurological disorders
History of pelvic surgery
Pregnancy
Active intestinal disease and fissure
Neurological diseases (such as multiple sclerosis, stroke)
Urine test and positive urine culture
History of radiation therapy or hormone therapy in the last six months
Prolapse of the pelvic organs more than grade 2 (more than 1 cm below Hyman's membrane during the examination in the stretched state of the pelvic floor. Grading will be done through the quantitative system of pelvic organ prolapse and by a gynecologist or pelvic floor physiotherapist. This The method has 5 grades from grade 0 to 4, grade 0 indicates the absence of prolapse, grade 1 is less than 1 cm below Hyman's curtain, grade 2 is more than 1 cm below Hyman's curtain, grade 3 is more than 1 cm. below the hymen, but does not protrude more than 2 cm from the entire length of the vagina, and in grade 4, the lower genital system is completely deviated
They were not able to contract the pelvic floor muscles during finger examination
Active or recurrent urinary tract infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: Questionnaires.;Treatment time. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: GEE model.;Frequency of incontinence. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: Three day bladder diary.;Activity of pelvicfloor muscles. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: Examining the strength, resting tone, resting activity and sneezing or coughing pelvic floor muscles through electromyography.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: Questionnaires.;Pelvic floor muscle activity. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: Electromyography.;Treatment time. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: GEE model.;Frequency of incontinence. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: Three day bladder diary.